We have moved
to

3rd Floor, New Liverpool House
15 Eldon Street, London, EC2M 7LD


Online Ticketing powered by Eventbrite

News & Events

We will be hosting our next Investor Forum at Fasken Martineau, on the evening of Wednesday 23rd September and are delighted to invite you to attend and meet the management of Stadium Group, Motif Bio and a third growth company to be confirmed soon.

Register here

Stadium Group (SDM)

Stadium is a leading provider of design-led integrated electronic technologies to the global electronics market with design and manufacturing operations in the UK and Asia. In July it announced the acquisition of UK power solutions company Stontronics for £6.5m cash, partly funded by a Firm Placing, and a Placing and Open Offer, of a total of 5.45 million shares at 110p. Stadium will report its Interim results (for the 6 months to 30 June) on 8 September. 
Chief Executive, Charlie Peppiatt, will represent the company.
 

Motif Bio (MTFB)

Motif is a clinical stage biopharmaceutical company, which specialises in developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. The company has a lead antibiotic candidate, iclaprim, in clinical development. Motif IPO'd on AIM in April this year, raising £2.8 million at 20p. In June it raised a further £22 million at 50p to help it in its aim of commercialising iclaprim within 36 months of IPO. 
Graham Lumsden, CEO, will be presenting.

 
Venue: Fasken Martineau, 17 Hanover Square, London, W1S 1HU

Time: 5.00pm for a prompt 5.30pm start, 35 mins for each company to present and answer questions, then drinks and canapés to follow at 7.15pm.

Date: Wednesday 23rd of September

Please contact: gilbert@equitydevelopment.co.uk with any questions.

-------------------------------------------------------------------------------------------

 

HEDGE FUND MANAGERS | HEDGE FUND ANALYSTS | HEDGE FUND RESEARCHERS | FINANCIAL MARKET RESEARCHERS | COMPANY VALUES RESEARCH | LISTED COMPANIES RESEARCH FIGURES | COMPANY PERFORMANCE RESEARCH | INVESTMENT ROAD SHOWS | PRIVATE COMPANIES RESEARCH FIGURES | COMPANY RESEARCH DATA | INVESTMENT SECTORS NEWS | INVESTMENT MARKET COMMENT | EQUITY DEVELOPMENT, LONDON | EQUITY DEVELOPMENT NEWS | INVESTMENT NEWS |